Nothing changed in a day. Likely going sub $1 and might force a reverse split at some point. Becomes a bio penny stock. They should announce some interim results if possible, probably by the end of the year they'll have 10 or more patients who completed the whole trial in the study drug.
News 
Market Data 
Discover 
